JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5191.2M
Enterprise Value 3-47.24M
Trailing P/E N/A
Forward P/E 1-4.88
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.10
Price/Book (mrq)1.76
Enterprise Value/Revenue 3-0.77
Enterprise Value/EBITDA 61.49

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin -50.54%
Operating Margin (ttm)-57.35%

Management Effectiveness

Return on Assets (ttm)-7.49%
Return on Equity (ttm)-21.94%

Income Statement

Revenue (ttm)61.64M
Revenue Per Share (ttm)1.91
Quarterly Revenue Growth (yoy)-4.50%
Gross Profit (ttm)38.82M
EBITDA -31.61M
Net Income Avi to Common (ttm)-31.15M
Diluted EPS (ttm)-0.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)232.71M
Total Cash Per Share (mrq)7.14
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.58
Book Value Per Share (mrq)3.33

Cash Flow Statement

Operating Cash Flow (ttm)-74.41M
Levered Free Cash Flow (ttm)-22.73M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-59.80%
S&P500 52-Week Change 39.79%
52 Week High 329.25
52 Week Low 35.51
50-Day Moving Average 36.83
200-Day Moving Average 310.55

Share Statistics

Avg Vol (3 month) 3278.67k
Avg Vol (10 day) 3234.1k
Shares Outstanding 532.63M
Float 15.64M
% Held by Insiders 115.13%
% Held by Institutions 182.88%
Shares Short (Sep 28, 2018) 43.38M
Short Ratio (Sep 28, 2018) 413.5
Short % of Float (Sep 28, 2018) 421.67%
Short % of Shares Outstanding (Sep 28, 2018) 410.36%
Shares Short (prior month Aug 31, 2018) 43.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A